Check out some great brain imaging as it relates to the circuitry of addiction:
via National Geographic
Check out some great brain imaging as it relates to the circuitry of addiction:
via National Geographic
✔️ Superficial Heat
✔️ Massage, Acupuntcure & Chiropractic
✔️ Stretching & Yoga
✔️ Cognitive Behavioral Therapy
✔️ Fitness & Exercise
Brody, J. E. (2017, September 11). Alternatives to Drugs for Treating Pain. Retrieved October 10, 2017, from https://www.nytimes.com/2017/09/11/well/alternatives-to-drugs-for-treating-pain.html
NeuroStar® Advanced Therapy Extends Depression Research Leadership with New Data at U.S. Psych Congress
The NeuroStar Outcomes Registry surpasses 750 patient milestone and validates real-world outcomes for TMS therapy depression treatment
MALVERN, Pa., September 15, 2017 - NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), will present clinical data and key findings from its outcomes registry and other data at the 2017 U.S. Psychiatric & Mental Health Congress (Psych Congress) in New Orleans, September 16-19, 2017. Psych Congress, celebrating its 30th anniversary, is the nation's leading independent mental health continuing education conference for advancing psychopharmacology, psychotherapy and wellness.
NeuroStar's depression outcomes registry, which launched in November 2016 to further investigate and better understand the use of the transcranial magnetic stimulation therapy in a clinical setting, has reached 781 patients across approximately 50 treatment facilities in the United States. The registry is projected to grow to 6,000 patients across 100 different treatment facilities by 2019 - making it one of the largest registries for depression treatment.
"NeuroStar is the leader in clinical research for transcranial magnetic stimulation therapy and is also backed by the largest clinical data set for Major Depressive Disorder of any TMS device. The important research by NeuroStar provides validation for the effectiveness of the therapy in treating chronic depression and offers tremendous potential for treatment advancements and new applications," said Kimberly Cress, M.D., TMS Serenity Center. "I'm truly excited to be one of the doctors participating in the NeuroStar Outcomes Registry and to have access to pivotal data that helps me better understand and address the needs of my patients. I commend NeuroStar for continuing to deliver powerful research that helps advance the understanding of transcranial magnetic stimulation as a legitimate, second-line treatment option for anyone struggling with depression who isn't benefiting from antidepressants."
Three poster presentations will occur during the 2017 Psych Congress (Sunday 1:30, Sunday 5:30, and Monday 1:30). The topics of these posters are:
NeuroStar Outcomes Registry
Results from the NeuroStar Outcomes Registry further validate real-world NeuroStar treatment outcomes seen in open-label clinical trials. On a clinician rating scale (CGI-S), 76 percent of patients responded to the treatment and experienced significant improvement, and 59 percent achieved remission of their depression symptoms - demonstrating the proven efficacy of NeuroStar. The NeuroStar Outcomes Registry is powered by its TrakStar™ technology, which is the only transcranial magnetic stimulation patient data management system that automaticallytracks treatment information, patient history, and clinical outcomes, maximizing coordination of care.
Optimizing TMS Treatment for Depression: The 19-Minute Dash™ Protocol
NeuroStar conducted an analysis to evaluate a reduced treatment time from 37.5 minutes to under 19 minutes* by decreasing the time between pulse sequences, which would improve patients' comfort and convenience yet still retain the efficacy and safety of the treatment. NeuroStar's analysis confirmed that the variables which impact treatment efficacy are the number of treatment sessions, the number of pulses per session, and the percent motor threshold. Varying or shortening the length of time between pulses does not negatively impact the safety or efficacy of the NeuroStar treatment.
Controlled Trial of NeuroStar in Adolescent Patients
Major Depressive Disorder is a major health problem for adolescents, yet current treatment options frequently fail to provide adequate clinical improvement or are deemed unacceptable to patients and their families. NeuroStar has launched the first-ever randomized, controlled clinical trial to evaluate this unmet need and the acute and long-term effectiveness of NeuroStar in adolescent and young adult patients ages 12 to 21. The trial will evaluate the safety and efficacy of NeuroStar in approximately 100 patients in study sites across the U.S. , using a six-week acute treatment course with six month follow up. NeuroStar is currently enrolling for this clinical trial (NCT #02586688) and expects enrollment to be completed by the end of 2017.
Approximately 4.3 million Americans treated for depression do not benefit from antidepressant medication. With nearly 1.5 million treatments delivered to date, NeuroStar Advanced Therapy was cleared by the FDA in 2008 as a safe and effective second-line treatment option for adult patients with Major Depressive Disorder who have not seen success with at least one antidepressant medication. It is available by prescription and typically administered daily in a doctor's office for four to six weeks. NeuroStar is improving patient access to this therapy with its widespread insurance coverage and enhanced scheduling convenience as the first FDA-cleared TMS treatment that can be delivered in under 19 minutes. Additionally, there has been a 20 percent increase in the number of NeuroStar systems across the country in the past year. The non-drug, non-invasive treatment uses magnetic pulses to stimulate areas of the brain that are underactive in depression. It is not electroconvulsive therapy (ECT) and uses a different mechanism than ECT. Backed with the most clinical studies for transcranial magnetic stimulation in depression,,, NeuroStar Advanced Therapy is free from side effects often associated with antidepressants.
For more information about NeuroStar Advanced Therapy, visit www.NeuroStar.com.
About NeuroStar® Advanced Therapy
NeuroStar Advanced Therapy is the established leader in transcranial magnetic stimulation (TMS), a non-invasive form of neuromodulation. It is backed by the largest clinical data set for Major Depressive Disorder (MDD) of any TMS device. NeuroStar Advanced Therapy is the #1 physician-preferred TMS treatment for patients with MDD, and there are over 800 NeuroStar systems in 49 states.
With over 300 million covered lives, NeuroStar is widely reimbursed by most commercial and government health plans, including Medicare and Tricare. In addition, there are programs in place, such as NeuroStar Reimbursement Support, to help patients and providers obtain coverage and reimbursement for NeuroStar Advanced Therapy.
NeuroStar is indicated for the treatment of MDD in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode. In an NIMH-funded, independent, randomized controlled trial, patients treated with transcranial magnetic stimulation using a clinical-trial version of the NeuroStar System were four times more likely to achieve remission compared to patients receiving sham treatment (P = 0.0173; odds ratio = 4.05). The most common side effect is pain or discomfort at or near the treatment site, which usually resolves within one week. It is contraindicated in people with non-removable conductive metal in or near the head. Long-term durability of effect has not been established in a randomized controlled trial.
For more information and full safety and prescribing information, visit www.NeuroStar.com.
Ban high-dose opioid painkillers, groups urge FDA. (2017, August 31). Retrieved September 13, 2017, from https://www.today.com/health/groups-urge-fda-ban-high-dose-opioid-painkillers-t115800
☑️ See stress as your body's way of preparing you to excel
☑️ Gradual exposure to small stressors can serve as a great foundation for handling life's bigger stressors which are inevitable
☑️ Regular exercise is very effective in reducing the irritability that comes with stress
Parker-Pope, T. (n.d.). How to Be Better at Stress. Retrieved September 05, 2017, from https://www.nytimes.com/guides/well/how-to-deal-with-stress
⭕️ Research at the University of Cincinnati has found a correlation between acidosis, an excessively acid condition of the body's fluids or tissues, and panic attacks.
⭕️ Gene-8 (TDAG8) receptors are associated with T-cell death, and an increasing presence of these receptors correlates to more severe panic attacks.
⭕️ Further research is needed to determine how the presence of these receptors is influenced by genetics versus environmental factors.
Nauert, R. (2017, August 25). Progress Toward Identifying Biological Source for Panic Disorder. Retrieved August 29, 2017, from https://psychcentral.com/news/2017/08/25/progress-toward-identifying-biological-source-for-panic-disorder
Crist, C. (2017, August 09). Pediatricians offer strategies for talking to kids about bad news. Retrieved August 29, 2017, from https://www.reuters.com/article/us-children-communication-idUSKBN1AP2HV
Moreno MA. How to Talk to Your Children About Tragedies in the News. JAMA Pediatr. Published online August 07, 2017. doi:10.1001/jamapediatrics.2017.2351
While the study is still in progress, his work has indicated that there are certain lifetime behaviors and/or tendencies that can influence the onset of Alzheimers later in life.
Dr. Snowden believes that idea density and positivity have something to do with Alzheimer's prevention. This ongoing longitudinal study focuses on an ideal population in terms of a uniform lifestyle amongst its subjects (the nuns). And because lifetime journaling is regular for nuns, Dr. Snowden has been able to use journal entries from early adulthood as a reference to identify things like idea density (complexity, vivacity, fluency, etc.) and positive thinking. What he continues to find is that these two variables are key indicators in determining which subjects developed Alzheimer's later in life. In fact, roughly 80% of the nuns identified as lacking linguistic density and positive thinking went on to develop Alzheimer's later in life, compared to only 10% amongst those not lacking. Confirmation bias could certainly be at play, but these figures definitely give legitimacy to how reinforcing neural pathways can preserve the function of the human brain. Some nuns are even calling for further structural analysis of the brain...
“Through brain donation, we can help unravel the mysteries of Alzheimer’s disease"
- Sister R. Schwalbe
Belluck, P. (2001, May 06). Nuns Offer Clues to Alzheimer's and Aging. Retrieved August 23, 2017, from http://www.nytimes.com/2001/05/07/us/nuns-offer-clues-to-alzheimer-s-and-aging.html
[Ethan Rozin]. (2006, Dec. 28). nun study video. [Video File]. Retrieved from https://www.youtube.com/watch?v=nw2lafKIEio.
R. (2012, April 26). Aging with Grace. Retrieved August 23, 2017, from https://robinmd.wordpress.com/2012/04/26/aging-with-grace/
Cleantis, T. (2011, February 16). How to Find the Best Therapist for You. Retrieved August 21, 2017, from https://www.psychologytoday.com/blog/freudian-sip/201102/how-find-the-best-therapist-you
Use Psychotherapy (Counseling) to help identify things like trigger points and thought patterns as a result of your brain's fast and slow thinking responses. This is the foundation to desensitizing the body's physiological reaction when dealing with conditions like PTSD and Anxiety.
[Limbix, Inc.]. (2017, Jun. 15) Limbix: Modern Therapy Tools. [Video File]. Retrieved from https://www.youtube.com/watch?v=0tsNE6cSbMg
Metz, C. (2017, July 30). A New Way for Therapists to Get Inside Heads: Virtual Reality. Retrieved August 09, 2017, from https://www.nytimes.com/2017/07/30/technology/virtual-reality-limbix-mental-health.html
✔️ Smiling to feel happier or dressing up for an interview to be on top of your game actually work!
✔️ Practice Mindfulness by staying in the moment and knowing nothing is perfect.
✔️ Use body language to your advantage! Standing tall like Super Woman will cause your brain to release chemicals that increase and stabilize your confidence.
Kaplan, E. (2017, April 07). How to Replace Your Self-Doubt With Unshakeable Confidence. Retrieved August 08, 2017, from https://journal.thriveglobal.com/how-to-replace-your-self-doubt-with-unshakable-confidence-fc9bf59615c5
[Ted]. (2012, Oct. 1). Your body language may shape who you are | Amy Cuddy. [Video File]. Retrieved from https://www.youtube.com/watch?v=Ks-_Mh1QhMc
Monterosso, J. (2017, July 21). A Psychology and Neuroscience Professor Explains What We Get Wrong About Gratitude. Retrieved July 31, 2017, from https://www.thriveglobal.com/stories/10813-the-trouble-with-gratitude
About Heads Together. (n.d.). Retirved July 10, 2017, from https://www.headstogether.org.uk/about-heads-together/
Patrons_heads_together [Photograph found in Royal Foundation]. (n.d.). Retrieved July 10, 2017, from http://www.royalfoundation.com/heads-together-duke-duchess-cambridge-prince-harry-working-eliminate-stigma-around-mental-health/
[Heads Together]. (2017, Feb. 21). Heads Together | Prince Harry's speech at Heads Together Training Day in Newcastle. [Video File]. Retrieved from https://www.youtube.com/watch?v=gUL9tmPZ8XI&t=1s
[Heads Together]. (2017, Apr. 21). Catherine, William + Harry | Heads Together| #oktosay. [Video File]. Retrived from https://www.youtube.com/watch?v=45RqUmxDXiY
▪️ In 2009 Martha Rhodes discovered TMS Therapy as a treatment option for depression.
▪️ After going through 6 weeks of treatment, Rhodes was able to successfully achieve full remission from what had been a very treatment-resistant case of Major Depressive Disorder prior to that.
▪️ In her autobiography, 3000 Pulses Later, Rhodes talks about her experience before and after completing TMS Therapy and specifically about her remarkable turnaround as a result of this treatment.
[Emory University]. (2016, Jan. 6). OTT: TMS - Depression, TMS & Emory. [Video File] Retrieved from https://www.youtube.com/watch?v=Z6NG3DvcZGI
Martha Rhodes; a TMS Success Story | Part I. (2013, April 05). Retrieved July 24, 2017, from http://tmsneuro.com/depression-treatments/martha-rhodes-a-tms-success-story-part-i/
→ The Netflix original series, "13 Reasons Why" has become the most tweeted about show in 2017.
→ The drama-mystery series based on the novel by Jay Asher focuses on the story of a teen who commits suicide.
→ The number of teens and young children that have been hospitalized for suicidal thoughts and actions has doubled in the past decade. Naturally, parents are concerned about how this series may affect its viewers, an already vulnerable population.
McCarthy, M. C. (2017, May 03). 5 things to tell your child about 13 Reasons Why. Retrieved July 16, 2017, from http://www.health.harvard.edu/blog/5-things-tell-child-13-reasons-2017050211695
Peterson, K. (2017, May 08). The controversy behind Netflix's teen-suicide drama '13 Reasons Why' - and why it's hitting close to home. Retrieved July 17, 2017, from http://www.sandiegouniontribune.com/entertainment/tv/sd-me-thirteen-reasons-20170508-story.html
Scutti, S. (2017, May 05). 'Alarming' rise in children hospitalized with suicidal thoughts or actions. Retrieved July 17, 2017, from http://www.cnn.com/2017/05/05/health/children-teens-suicide-study/index.html
😷 😷 😷
P. (2017, July 10). A Boss' Response to an Employee Taking a Mental Health Day Is Going Viral. Retrieved July 16, 2017, from https://www.attn.com/stories/18200/how-email-helping-break-mental-health-stigma?utm_source=facebook&utm_medium=post&utm_campaign=internal
Miller, S. G. (2016, December 13). 1 in 6 Americans Takes a Psychiatric Drug. Retrieved July 16, 2017, from https://www.scientificamerican.com/article/1-in-6-americans-takes-a-psychiatric-drug/